HK1224205A1 - 共濟蛋白增强劑 - Google Patents

共濟蛋白增强劑

Info

Publication number
HK1224205A1
HK1224205A1 HK16112563.4A HK16112563A HK1224205A1 HK 1224205 A1 HK1224205 A1 HK 1224205A1 HK 16112563 A HK16112563 A HK 16112563A HK 1224205 A1 HK1224205 A1 HK 1224205A1
Authority
HK
Hong Kong
Prior art keywords
frataxin
enhancer
frataxin enhancer
Prior art date
Application number
HK16112563.4A
Other languages
English (en)
Inventor
Taku Chibazakura
Tohru Tanaka
Fuminori Abe
Motowo Nakajima
Atsuko Kamiya
Naoml Haga
Kiwamu Taka-Hashi
Original Assignee
Univ Tokyo Agriculture
Sbi Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokyo Agriculture, Sbi Pharmaceuticals Co Ltd filed Critical Univ Tokyo Agriculture
Publication of HK1224205A1 publication Critical patent/HK1224205A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16112563.4A 2013-10-29 2016-11-01 共濟蛋白增强劑 HK1224205A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013223929 2013-10-29
PCT/JP2014/078121 WO2015064447A1 (ja) 2013-10-29 2014-10-22 フラタキシン増強剤

Publications (1)

Publication Number Publication Date
HK1224205A1 true HK1224205A1 (zh) 2017-08-18

Family

ID=53004055

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16112563.4A HK1224205A1 (zh) 2013-10-29 2016-11-01 共濟蛋白增强劑
HK16112560.7A HK1224204A1 (zh) 2013-10-29 2016-11-01 共濟蛋白增强劑

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16112560.7A HK1224204A1 (zh) 2013-10-29 2016-11-01 共濟蛋白增强劑

Country Status (6)

Country Link
US (1) US20160271090A1 (zh)
EP (1) EP3064202A4 (zh)
JP (1) JP6177343B2 (zh)
CN (1) CN105744933A (zh)
HK (2) HK1224205A1 (zh)
WO (1) WO2015064447A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3613434A4 (en) * 2017-04-18 2020-12-23 SBI Pharmaceuticals Co., Ltd. AMPLIFIER OF A PHOTODYNAMIC EFFECT IN ALA-PDT OR ALA-PDD
JP7104037B2 (ja) * 2017-06-23 2022-07-20 Ｓｂｉファーマ株式会社 神経障害を改善するための医薬組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754731B2 (ja) * 2001-07-31 2011-08-24 コスモ石油株式会社 豚成育促進剤及び豚成育促進方法
AT500929B1 (de) * 2004-11-09 2007-03-15 Medizinische Uni Wien Muw Pharmazeutische zubereitung die erythropoietin enthält
AU2006278504B2 (en) * 2005-08-04 2013-01-17 Sirtris Pharmaceuticals, Inc. Imidazopyridine derivatives as sirtuin modulating agents
EP1951656B1 (en) 2005-11-11 2015-08-05 The Scripps Research Institute Histone deacetylase inhibitors as therapeutics for neurological diseases
EP1876846B1 (en) * 2006-07-03 2009-09-09 Samsung Electronics Co., Ltd. System and method for performing periodic ranging in sleep mode in a communication system
JP5098051B2 (ja) * 2007-04-05 2012-12-12 Ｓｂｉファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
EA201001814A1 (ru) * 2008-05-22 2011-04-29 Эдисон Фармасьютикалз, Инк. Лечение митохондриальных заболеваний миметиками эритропоэтина
EP3192506A3 (en) * 2008-10-27 2017-10-25 SBI Pharmaceuticals Co., Ltd. Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient
JP5611548B2 (ja) * 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
KR102043422B1 (ko) * 2011-06-09 2019-11-11 큐알엔에이, 인크. 프라탁신 (fxn)에 대한 자연 안티센스 전사체의 저해에 의한 프라탁신 (fxn) 관련된 질환의 치료
JP5881722B2 (ja) * 2011-10-12 2016-03-09 Ｓｂｉファーマ株式会社 がん性貧血改善・予防剤
WO2013054756A1 (ja) * 2011-10-12 2013-04-18 Ｓｂｉファーマ株式会社 抗ガン剤の副作用の予防剤及び／又は治療剤
WO2013054755A1 (ja) * 2011-10-12 2013-04-18 Ｓｂｉファーマ株式会社 エリスロポエチン産生促進剤

Also Published As

Publication number Publication date
HK1224204A1 (zh) 2017-08-18
JPWO2015064447A1 (ja) 2017-03-09
EP3064202A1 (en) 2016-09-07
EP3064202A4 (en) 2017-03-29
JP6177343B2 (ja) 2017-08-09
WO2015064447A1 (ja) 2015-05-07
CN105744933A (zh) 2016-07-06
US20160271090A1 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
HK1222846A1 (zh) 取代的苄基吡唑
HK1221717A1 (zh) 取代的苄基吡唑
HK1221421A1 (zh) 抗增生性化合物
AP2015008713A0 (en) Tetrahydropyrrolothiazine compounds
GB201309085D0 (en) Compounds
GB201302927D0 (en) Compounds
HRP20171890T1 (hr) Supstituirani imidazopiridazini
HK1218840A1 (zh) 碳酸刺激增强劑
GB201309508D0 (en) Compounds
HK1223362A1 (zh) 取代的吡唑並吡啶胺
HK1220972A1 (zh) 取代的噻唑並嘧啶
AP3850A (en) Azetidinyloxyphenylpyrrolidine compounds
IL246271A0 (en) Converted piperidinyl-tetrahydroquinolines
EP3010923A4 (en) PYRROLOCHINAZOLINVERBINDUNGEN
HK1224204A1 (zh) 共濟蛋白增强劑
EP2948457A4 (en) COMPOUNDS
GB201315616D0 (en) Signal enhancer
GB201304460D0 (en) Biomarker
GB201306794D0 (en) Compounds
GB201319812D0 (en) Lavark variations
GB201317911D0 (en) E e e
GB201308261D0 (en) Novel antiproliferative compounds
GB201304305D0 (en) E C Trackograph
GB201309728D0 (en) Compounds
GB201309015D0 (en) Compounds